Enrico Ferro: Stroke Risk in PFA vs Radiofrequency Ablation
Enrico Ferro, Electrophysiology Fellow at Beth Israel Lahey Health, Clinical Investigator at Richard A. and Susan F. Smith Center for Outcomes Research, shared on LinkedIn:
”Honored that our comparative analysis of stroke rates between PFA and radiofrequency ablation for AFib was covered by John Mandrola in Medscape This Week in Cardiology!
John Mandrola, given your always careful and nuanced analyses of scientific evidence, our team Beth Israel Deaconess Medical Center and Richard A. and Susan F. Smith Center for Outcomes Research was happy to receive your positive feedback for our study.
As you point out, the stroke event rates are low, but we are reproducing this design with a much larger nationwide database, while still preserving deep clinical phenotyping for appropriate risk-adjustment.
Stay tuned!”
Stay updated with Hemostasis Today.
-
Apr 29, 2026, 07:12Matteo Foschi: Is There a Benefit to Switching DOACs After Breakthrough Stroke?
-
Apr 29, 2026, 06:03Proud to Recognize 6 Early Career Investigators as the Recipients of the 2026 JTH Editors’ Awards – JTH
-
Apr 29, 2026, 05:55On Hemophilia Care Advances, Collaboration and Access in India at IHC X 2026 – Hemophilia Federation India
-
Apr 29, 2026, 05:46Rajendra Tapadia: Strengthening Last-Mile Hemophilia Care Through Structured Community Outreach
-
Apr 29, 2026, 05:37Masoabi Sefojane: Whose Realities Shape Global Priorities in Hemophilia Care?
-
Apr 29, 2026, 05:24Filippo Cademartiri: Mandatory Reading for Anyone Who Mistakes Expertise for Certainty
-
Apr 29, 2026, 02:52Fengqian Chen: Another Reality Check for the Factor XI Inhibitor Race – Novartis’ Abelacimab Setback
-
Apr 29, 2026, 02:18Arnaud Baldivia: Peri-Procedural Stroke – An Underestimated Emergency in the Operating Room and in the ICU
-
Apr 29, 2026, 02:04Yazhini Selvaraj: What is Plasmapheresis?